Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article (73)

Advertisement

Research Article Free access | 10.1172/JCI107696

Partial Purification of Osteoclast-Activating Factor from Phytohemagglutinin-Stimulated Human Leukocytes

Richard A. Luben, Gregory R. Mundy, Clarence L. Trummel, and Lawrence G. Raisz

Department of Pharmacology and Toxicology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

Department of Clinical Dentistry, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

Find articles by Luben, R. in: PubMed | Google Scholar

Department of Pharmacology and Toxicology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

Department of Clinical Dentistry, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

Find articles by Mundy, G. in: PubMed | Google Scholar

Department of Pharmacology and Toxicology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

Department of Clinical Dentistry, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

Find articles by Trummel, C. in: PubMed | Google Scholar

Department of Pharmacology and Toxicology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

Department of Clinical Dentistry, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

Find articles by Raisz, L. in: PubMed | Google Scholar

Published May 1, 1974 - More info

Published in Volume 53, Issue 5 on May 1, 1974
J Clin Invest. 1974;53(5):1473–1480. https://doi.org/10.1172/JCI107696.
© 1974 The American Society for Clinical Investigation
Published May 1, 1974 - Version history
View PDF
Abstract

Osteoclast-activating factor (OAF) is a soluble mediator found in supernates of human peripheral leukocytes which have been cultured with antigens or phytomitogens. OAF is a potent stimulator of osteoclastic resorption of fetal bone in organ culture. The present studies were designed to characterize OAF chemically. Bone resorbing activity from supernates of leukocytes cultured without added plasma was not lost on dialysis using a membrane with a molecular weight cutoff of 3,500, but was lost when heated to 60°C for 30 min. The activity was lost after treatment with trypsin or pronase but not after treatment with ribonuclease or neuraminidase. Papain, which inactivated parathyroid hormone at a concentration of 25 μg/ml, did not inactivate OAF at 250 μg/ml. OAF did not react with an antibody to bovine parathyroid hormone which cross-reacts with human parathyroid hormone. OAF was also distinguished from active metabolites of vitamin D and from prostaglandin by extraction procedures and immunoassay for prostaglandin E2.

When the medium from activated leukocytes cultured with autologous plasma was fractionated by gel filtration on Sephadex, bone resorbing activity eluated both with plasma proteins and in lower molecular weight fractions. However, when medium from leukocytes cultured without added plasma was chromatographed, all the OAF activity was eluted in a sharp low molecular weight peak located between chymotrypsinogen (25,000 molecular weight) and ribonuclease A (13,700 molecular weight). This peak contained about 4% of the total protein originally present in the supernate. Its activity was destroyed by overnight incubation at 37°C at pH 6 or 8, but not at pH 7.2. After incubation at 4°C, the activity was lost at pH 3 or 10, but not at pH 4-9.

The active fraction from Sephadex G-100 was therefore chromatographed at pH 7.2 on DEAE cellulose and carboxymethyl cellulose. The active material was not adsorbed; however, about sevenfold further purification was achieved by removal of contaminants. The material obtained after sequential Sephadex, DEAE and, carboxymethyl cellulose chromatography stimulated resorption of fetal rat bone in culture at concentrations of 0.75-3 μg protein/ml, indicating that this preparation of OAF was nearly as potent as bovine parathyroid hormone in this system.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1473
page 1473
icon of scanned page 1474
page 1474
icon of scanned page 1475
page 1475
icon of scanned page 1476
page 1476
icon of scanned page 1477
page 1477
icon of scanned page 1478
page 1478
icon of scanned page 1479
page 1479
icon of scanned page 1480
page 1480
Version history
  • Version 1 (May 1, 1974): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (73)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts